Evidence map›Paper›PMID 42450063›Full record

ArticleInternational journal of molecular sciences2026

Exploring the Role of the Laforin/Malin Complex in Rubicon-Dependent Phagocytosis.

Laura Baños-Carrión, Maria Adelaida García-Gimeno, Pascual Sanz

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura Baños-CarriónInstituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas, Jaime Roig 11, 46010 Valencia, Spain.
Maria Adelaida García-GimenoDepartment of Biotechnology, Escuela Técnica Superior de Ingeniería Agronómica y del Medio Natural, Universitat Politécnica de València, 46022 Valencia, Spain.ORCID 0000-0002-6483-3912
Pascual SanzInstituto de Biomedicina de Valencia, Consejo Superior de Investigaciones Científicas, Jaime Roig 11, 46010 Valencia, Spain.ORCID 0000-0002-2399-4103

Funding

Centro de Investigación Biomédica en Red CIBERER ACCI2023-03-742Ministerio de Ciencia, Innovación y Universidades PID2023-1481023OB-I00Programa Prometeo Generalitat Valenciana CIPROM2022/42
6 · The paper itself

Abstract

Lafora disease (LD) is a fatal neurodegenerative disorder caused by mutations in the

Indexed as

Carrier ProteinsDual-Specificity PhosphatasesLafora DiseasePhagocytosisProtein Tyrosine Phosphatases, Non-ReceptorUbiquitin-Protein LigasesAnimalsAstrocytesAutophagyHEK293 CellsHumansMiceMicrogliaProtein BindingUbiquitinationCarrier ProteinsDual-Specificity PhosphatasesEPM2A protein, humanEpm2a protein, mouseNHLRC1 protein, humanNHLRC1 protein, mouseProtein Tyrosine Phosphatases, Non-ReceptorUbiquitin-Protein LigasesastrocytesLafora diseaseLANDOLAPMalinneuroinflammationRubiconubiquitination

Identifiers

PMID42450063
PMCPMC13362185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.